H&R Block, Inc.
HRB
$35.89
-3.55%
H&R Block, Inc. is a leading provider of income tax return preparation services, digital do-it-yourself (DIY) tax solutions, and related financial products in the United States, Canada, and Australia. The company is a dominant player in the assisted tax preparation market, operating through a vast network of company-owned and franchised offices, which distinguishes it from pure-play digital competitors. The current investor narrative revolves around the company's strategic pivot to defend its core assisted business against intensifying competition from low-cost and free digital platforms, while simultaneously investing to grow its own digital DIY segment and expand its financial services offerings, amid a backdrop of significant stock price volatility and a challenging post-tax-season period.…
HRB
H&R Block, Inc.
$35.89
Investment Opinion: Should I buy HRB Today?
Rating: Hold. The thesis is that HRB presents a high-risk, high-reward speculative value play, where a successful tax season could validate the cheap forward multiple, but significant financial and competitive risks warrant extreme caution.
Supporting evidence includes the compelling forward P/E of 6.52x, which is less than half the trailing multiple, implying a substantial earnings rebound. Analyst consensus expects EPS of $7.74 on revenue of ~$4.20B, providing a concrete benchmark for the upcoming season. The stock's 22.14% surge over the past month shows powerful, albeit volatile, buying interest at depressed levels. However, this is countered by a weak current ratio of 0.90 and a severe -35.56% one-year return that underscores persistent fundamental concerns.
The thesis would upgrade to a Buy if the stock demonstrates sustained technical strength above the $40-$42 resistance zone on strong pre-tax season volume, and/or if Q4 earnings preliminaries confirm the path to the $7.74 EPS target. It would downgrade to a Sell if the price breaks back below the $30 support level, indicating the recent rally has failed, or if liquidity metrics worsen. Relative to its own battered history and the market's skepticism, the stock appears fairly valued for the immense risk it carries; it is not clearly undervalued without proof of an earnings recovery.
Sign up to view all
HRB 12-Month Price Forecast
The outlook is bifurcated between a deep-value recovery story and a secular decline narrative. The low forward P/E is the most compelling bullish argument, but it is entirely contingent on a successful tax season that reverses the catastrophic price trend. The neutral stance reflects this high uncertainty; the base case of range-bound trading is most probable as the market awaits concrete proof of the earnings rebound. Confidence is medium due to the lack of analyst consensus and recent extreme volatility. The stance would upgrade to bullish on a confirmed breakout above $42 with strong volume, or downgrade to bearish on a breakdown below $30 ahead of the key tax season.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on H&R Block, Inc.'s 12-month outlook, with a consensus price target around $46.66 and implied upside of +30.0% versus the current price.
Average Target
$46.66
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$29 - $47
Analyst target range
Analyst coverage for H&R Block is extremely limited, with data indicating only one analyst providing estimates, which constitutes insufficient analyst coverage for deriving a meaningful consensus. This minimal coverage typically signifies limited institutional interest, which can lead to higher stock price volatility and less efficient price discovery, as the stock is not widely followed or debated by the sell-side community. The single analyst's estimates project revenue between $4.15 billion and $4.22 billion, with an average of $4.20 billion, and EPS between $7.63 and $7.81, averaging $7.74; these figures suggest expectations for the core tax season business remain intact, but the absence of a price target or rating distribution prevents any calculation of implied upside or downside or an assessment of bullish or bearish sentiment.
Bulls vs Bears: HRB Investment Factors
The evidence is currently mixed but leans bearish due to the stock's entrenched long-term downtrend and fundamental financial concerns. The bull case is anchored in an exceptionally cheap forward valuation and a powerful short-term technical bounce from oversold levels. The bear case is supported by poor liquidity, high short interest, and a lack of analyst confidence. The single most important tension in the investment debate is whether the stock's extreme forward P/E of 6.52x correctly anticipates a strong seasonal earnings rebound that validates the recent price recovery, or whether it is a value trap signaling deeper, secular challenges to the core assisted tax business that will prevent earnings from materializing.
Bullish
- Extreme Forward Valuation Discount: The stock trades at a forward P/E of just 6.52x, based on analyst consensus EPS of $7.74. This represents a massive discount to the trailing P/E of 12.14x and suggests the market is pricing in a significant earnings recovery for the upcoming tax season.
- Strong Short-Term Momentum Reversal: After a brutal 54.64% drawdown, the stock has rebounded 22.14% over the past month, significantly outperforming the SPY's 5.05% gain. This sharp recovery from the 52-week low of $28.16 indicates potential capitulation and a technical bottom.
- Robust Underlying Profitability: The company maintains healthy operating and net margins of 22.01% and 16.11%, respectively. This demonstrates the core assisted tax preparation business remains highly profitable despite competitive pressures.
- Low Market Correlation: With a beta of 0.298, HRB's price action is largely idiosyncratic and has been 70% less volatile than the broader market. This low correlation can provide portfolio diversification benefits, especially during the stock's recent recovery phase.
Bearish
- Severe Long-Term Downtrend: The stock is down 35.56% over the past year and trades near 20% of its 52-week range, much closer to its low ($28.16) than its high ($58.81). This persistent downtrend signals deep-seated bearish sentiment and structural concerns.
- Liquidity and Balance Sheet Strain: A current ratio of 0.90 indicates current assets do not fully cover current liabilities, posing a potential liquidity risk. The high price-to-book ratio of 82.71, while an artifact of low equity, reflects a strained financial structure.
- Extremely Limited Analyst Coverage: Only one analyst provides estimates, indicating minimal institutional interest and potentially leading to higher volatility and inefficient price discovery. The lack of a consensus price target or rating adds significant uncertainty.
- High Short Interest: A short ratio of 6.39 is elevated, suggesting a substantial portion of the market remains skeptical of the recent rally and is betting on further downside. This creates a persistent overhang and potential for short squeezes on positive news.
HRB Technical Analysis
The stock is in a pronounced long-term downtrend, having declined 35.56% over the past year, and is currently trading at approximately 20% of its 52-week range, positioned much closer to its 52-week low of $28.16 than its high of $58.81. This deep drawdown of 54.64% signals severe bearish sentiment and suggests the stock is either presenting a deep-value opportunity or remains in a fundamental downtrend that has yet to find a durable bottom. Recent momentum, however, shows a sharp but volatile recovery attempt, with the price up 22.14% over the past month and 19.86% over the past three months, significantly outperforming the SPY's gains of 5.05% and 10.7%, respectively, over the same periods. This positive short-term divergence from the brutal yearly trend indicates a potential bear market rally or a capitulation low being established, though it remains within the context of the broader downtrend. Key technical levels are clearly defined, with major resistance at the 52-week high of $58.81 and immediate support at the recent low of $28.16; a sustained breakout above the $40-$42 area would be necessary to signal a more credible trend reversal. The stock's exceptionally low beta of 0.298 indicates it has been roughly 70% less volatile than the broader market during this period, which is atypical for a stock with such a large price decline and suggests its moves have been largely idiosyncratic, driven by company-specific news rather than macro factors.
Beta
0.37
0.37x market volatility
Max Drawdown
-54.0%
Largest decline past year
52-Week Range
$28-$58
Price range past year
Annual Return
-34.7%
Cumulative gain past year
| Period | HRB Return | S&P 500 |
|---|---|---|
| 1m | -2.1% | -0.1% |
| 3m | +17.6% | +11.4% |
| 6m | -17.1% | +8.2% |
| 1y | -34.7% | +22.7% |
| ytd | -15.8% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HRB Fundamental Analysis
Revenue and growth trajectory analysis is constrained as specific quarterly revenue figures and year-over-year growth rates are not available in the provided data; however, analyst estimates point to expected annual revenue of approximately $4.20 billion. The company's profitability metrics are mixed, with a trailing net margin of 16.11% and a gross margin of 44.53%, indicating it retains a healthy portion of revenue after cost of goods sold. The operating margin of 22.01% is robust, but the extremely low trailing EPS of $0.082 and a forward PE of just 6.52x suggest earnings are highly seasonal and concentrated in the tax filing period, with profitability outside of that season being minimal. The balance sheet and cash flow health appear strained based on available metrics; the current ratio of 0.90 indicates potential liquidity concerns, as current assets do not fully cover current liabilities, while a debt-to-equity ratio of 26.41 suggests a moderate level of leverage. Return on Equity (ROE) of 6.81% is modest, and the high price-to-book ratio of 82.71 is an artifact of low shareholder equity, not excessive market valuation, which together paint a picture of a company whose financial structure and returns are under scrutiny by the market.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HRB Overvalued?
Given the company's positive net margin, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 12.14x and a forward PE of 6.52x; the significant discount of the forward multiple implies the market expects a substantial recovery in earnings, likely tied to the upcoming tax season. Peer comparison is limited as industry average multiples are not provided in the data; however, a trailing PE of 12.14x and a Price-to-Sales (PS) ratio of 1.95x for a company with a 16% net margin could be considered value-oriented if growth prospects were stable, but the steep stock price decline suggests the market is discounting future challenges. Historical context for the valuation is unavailable as historical ratio data is not provided, making it impossible to determine if the current multiples are at historical lows or highs; this lack of context adds uncertainty to assessing whether the current price represents a cyclical bottom or a fundamental de-rating.
PE
12.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company's current ratio of 0.90 signals potential liquidity constraints, as it may struggle to meet short-term obligations without additional financing. While operating margins are robust at 22.01%, the extremely low trailing EPS of $0.082 highlights the extreme seasonality of earnings, making the company highly dependent on a successful tax season each year. The high price-to-book ratio of 82.71, stemming from low shareholder equity, indicates a fragile balance sheet that could amplify losses if revenue declines.
Market & Competitive Risks center on secular disruption and valuation compression. The stock's 35.56% annual decline and 54.64% max drawdown reflect the market's deep skepticism about HRB's ability to defend its core assisted business against low-cost and free digital DIY competitors. Despite the low forward P/E of 6.52x, the stock could face further multiple compression if growth prospects deteriorate. The exceptionally low beta of 0.298, while reducing macro correlation, confirms the stock's woes are company-specific, driven by competitive threats rather than broader market movements.
Worst-Case Scenario involves a failed tax season and a breakdown in the recent technical recovery. A combination of market share loss to digital competitors, a weaker-than-expected tax filing season, and a subsequent earnings miss could trigger a renewed sell-off. Investors could see a retest and break below the recent 52-week low of $28.16. From the current price of ~$38, this represents a realistic downside of approximately -26%. A failure to hold that level could lead to a steeper decline towards the $25-$27 range, reflecting a complete loss of confidence in the company's turnaround narrative.
FAQ
The key risks are: 1) Competitive Disruption: Loss of market share in its core assisted business to free/low-cost digital DIY platforms. 2) Financial Risk: A weak current ratio of 0.90 indicates potential liquidity strain. 3) Execution Risk: Failure to deliver on the anticipated ~$7.74 EPS during the critical tax season. 4) Sentiment Risk: Extremely limited analyst coverage (only one) and high short interest (short ratio 6.39) can lead to exaggerated price moves and volatility.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $36 and $42, assuming the company meets current EPS estimates of ~$7.74. The Bull Case (30% probability) targets $48 to $58 on a strong tax season and multiple expansion. The Bear Case (20% probability) warns of a drop to $28-$32 if earnings disappoint. The base case is most likely, hinging on the company hitting its seasonal earnings target.
Based on forward earnings, HRB appears deeply undervalued with a P/E of 6.52x. However, this valuation is contingent on a massive earnings rebound that has not yet occurred. The trailing P/E of 12.14x and Price-to-Sales of 1.95x are more reflective of its current profitability. The market is pricing in significant skepticism, implying the stock is fairly valued or even a 'value trap' until it proves it can deliver the expected seasonal earnings surge.
HRB is a high-risk, potentially high-reward stock that may be a good buy only for speculative, risk-tolerant investors who believe the upcoming tax season will be strong. The forward P/E of 6.52x offers significant upside if the company meets its $7.74 EPS target. However, with a 35.56% annual decline, liquidity concerns (current ratio 0.90), and high short interest, it carries substantial downside risk. It is not a good buy for conservative or income-focused investors.
HRB is primarily suitable for a tactical, short-to-medium term investment horizon centered on the tax season cycle. Its extreme seasonality, high volatility, and ongoing secular challenges make it a poor candidate for a traditional long-term 'buy and hold' strategy. Investors should have a minimum horizon of 6-12 months to capture the full tax season reporting cycle and subsequent market reaction. Its low beta of 0.298 does not make it a typical trading stock, but its price is driven by specific seasonal catalysts.